Nkx6 Transcription Factors and Ptf1a Function as Antagonistic Lineage Determinants in Multipotent Pancreatic Progenitors  by Schaffer, Ashleigh E. et al.
Developmental Cell
Short ArticleNkx6 Transcription Factors and Ptf1a Function
as Antagonistic Lineage Determinants
in Multipotent Pancreatic Progenitors
Ashleigh E. Schaffer,1,2 Kristine K. Freude,2 Shelley B. Nelson,2 and Maike Sander1,2,*
1Departments of Pediatrics and Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA 92093, USA
2Department of Developmental and Cell Biology, University of California, Irvine, Irvine, CA 92697, USA
*Correspondence: masander@ucsd.edu
DOI 10.1016/j.devcel.2010.05.015SUMMARY
The molecular mechanisms that underlie cell lineage
diversification of multipotent progenitors in the
pancreas are virtually unknown. Here we show that
the early fate choice of pancreatic progenitors
between the endocrine and acinar cell lineage is
restricted by cross-repressive interactions between
the transcription factors Nkx6.1/Nkx6.2 (Nkx6) and
Ptf1a. Using genetic loss- and gain-of-function
approaches, we demonstrate that Nkx6 factors and
Ptf1a are required and sufficient to repress the alter-
native lineage program and to specify progenitors
toward an endocrine or acinar fate, respectively.
The Nkx6/Ptf1a switch only operates during a critical
competencewindowwhen progenitors are still multi-
potent and can be uncoupled from cell differentia-
tion. Thus, cross-antagonism between Nkx6 and
Ptf1a in multipotent progenitors governs the equilib-
rium between endocrine and acinar cell neogenesis
required for normal pancreas development.
INTRODUCTION
At the earliest stages of pancreas development, most, if not all,
pancreatic epithelial cells are thought to be multipotent progen-
itors which are competent to develop into all pancreatic cell
types, namely five different endocrine lineages as well as the
exocrine acinar and ductal cells (Gu et al., 2002). During subse-
quent pancreasmorphogenesis, cells residing in the ‘‘tips’’ of the
branching epithelium adopt an acinar fate, whereas cells in the
core or ‘‘trunk’’ become restricted to a ductal or endocrine fate
(Solar et al., 2009; Zhou et al., 2007). Although significant
advances have been made in defining the molecular determi-
nants of endocrine cell subtype specification and differentiation
(Oliver-Krasinski and Stoffers, 2008), little is known regarding the
molecular mechanisms governing the early allocation of multipo-
tent progenitors to either a ductal/endocrine or acinar fate.
In many tissues, the separation of lineage-restricted progeni-
tors from a multipotent progenitor cell pool is mediated by
cross-repressive interactions between two transcription factors
(Briscoe et al., 2000; Laslo et al., 2006; Olguin et al., 2007). The1022 Developmental Cell 18, 1022–1029, June 15, 2010 ª2010 Elsevtranscriptional repressors Nkx6.1 and Nkx6.2 (Nkx6) constitute
one arm of such a cross-repressive loop during neuronal
subtype specification in the spinal cord (Sander et al., 2000a;
Vallstedt et al., 2001). In the pancreas, Nkx6.1 and Nkx6.2 are
redundantly required for endocrine a and b cell development
(Henseleit et al., 2005), but the mechanism by which Nkx6
factors control endocrine development has remained poorly
defined. The finding that coexpression of the two Nkx6 factors
is only observed in multipotent progenitors, but not in endocrine
lineage-committed progenitors marked by expression of the
transcription factor Neurogenin 3 (Ngn3) (Henseleit et al.,
2005), suggests that Nkx6 proteins play a key role in endocrine
cell development prior to the initiation of Ngn3 expression. This
raises the possibility that proper endocrine cell development
from amultipotent progenitor cell domain first requires the spec-
ification of endocrine fate by Nkx6 factors, whereas Ngn3 subse-
quently promotes cell differentiation by initiating cell cycle exit
and by inducing the expression of endocrine lineage-specific
genes (Apelqvist et al., 1999; Schwitzgebel et al., 2000). The
contention that Nkx6 proteins could be involved in early lineage
specification is consistent with the expression domain of Nkx6.1,
which becomes progressively compartmentalized to the trunk
domain, as the activator of acinar-specific gene transcription,
Ptf1a (Krapp et al., 1996; Rose et al., 2001), becomes exclusively
restricted to cells residing in the tips (Hald et al., 2008). Interest-
ingly, the resolution of Nkx6.1 and Ptf1a into exclusive compart-
ments appears to coincide with the progressive restriction of
trunk and tip cells to the ductal/endocrine or acinar cell lineage,
respectively (Solar et al., 2009; Zhou et al., 2007).
In this study, we provide evidence that reciprocal repression
between Nkx6 factors and Ptf1a enables a bistable switch in
multipotent progenitors that directs progenitors to adopt either
a ductal/endocrine or acinar cell fate.RESULTS
Loss of Nkx6 Activity Results in an Endocrine-to-Acinar
Fate Switch
To confirm that Nkx6.1 and Ptf1a resolve into exclusive compart-
ments (Hald et al., 2008) and to more carefully examine the
extent of coexpression between both Nkx6 factors and Ptf1a,
we performed coimmunofluorescence analysis for Nkx6.1 and
Nkx6.2 together with Ptf1a. At embryonic day (e) 10.5, a large
percentage of pancreatic epithelial cells coexpressed Nkx6.1ier Inc.
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transcription factors, although scarce, were also present
(Figure 1A). At the onset of branching morphogenesis at e12.5,
Nkx6.1 became progressively confined to the trunk of the devel-
oping organ, while Ptf1a marked the tips of the branches
(Figure 1B). At this stage, tip cells were additionally also largely
devoid of Nkx6.2 (Figure 1D). By e14.5, when tip cells have fully
committed to an acinar fate (Zhou et al., 2007), Nkx6.1 was
almost completely excluded from the tips and formed a sharp
boundary with Ptf1a (Figure 1C). As previously noted (Burlison
et al., 2008), from even the earliest stages of development,
Ngn3+ endocrine progenitors failed to express Ptf1a (Figure 1G).
To assess whether loss of Nkx6 gene function affects exclu-
sion of Ptf1a from the core of the developing pancreas, we
analyzed organ patterning in Nkx6.1;Nkx6.2 (Nkx6) compound
mutant mice, which exhibit normal organ size (see Figures
S1M and S1N available online). In Nkx6.1- and Nkx6-deficient
embryos, we detected significant ectopic expression of Ptf1a
in the trunk region (Figures 1K–1M and 1O), which was accom-
panied by a 90.7% reduction in the number of Ngn3+ cells at
e12.5 (Figures 1K–1N). At e10.5, when the majority of epithelial
cells express both Nkx6 factors (Henseleit et al., 2005), Nkx6.1
single mutants exhibited a smaller, 38.2% reduction in Ngn3+
cells, whereas Nkx6 compound mutants displayed a much
more extensive, 87.5% decrease compared to wild type
embryos (Figures 1G–1J). This suggests that compensation by
Nkx6.2 partially restores formation of Ngn3+ cells in Nkx6.1
single mutants at e10.5.
Because Ptf1a is a critical regulator of acinar cell differentia-
tion (Esni et al., 2004), we next examined whether expansion of
the Ptf1a+ domain in Nkx6 mutants manifests in increased
numbers of acinar cells. Transcriptional profiling and qRT-PCR
analysis of pancreatic anlagen indeed confirmed an upregulation
of acinar genes in Nkx6.1-deficient pancreata at e15.5 (Figures
1E and 1F), which was associated with increased numbers of
amylase+ acinar cells in Nkx6 mutants (Figures 1P–1R and 1T).
However, acinar cell markers did not appear prematurely
(Figures S1A–S1C), indicating that the absence of Nkx6 activity
does not affect the timing of acinar cell differentiation.
Significantly, in contrast to earlier developmental stages,
Nkx6-deficient embryos no longer displayed a reduction in
Ngn3+ progenitors at e14.5 (Figures 1P–1S). We speculate that
these Ngn3+ cells arise from a residual Ptf1a/Sox9+/Pdx1+
trunk-like progenitor cell domain that was still discernable in
Nkx6 mutants (Figures S1D–S1L) and might seed a partial
recovery of endocrine cell differentiation later during develop-
ment. The absence of the early but presence of the later wave
of Ngn3 cell genesis in Nkx6 mutants might also explain why
formation of a and b cells, but not of the later-arising d and
pancreatic polypeptide cells, is selectively affected in Nkx6
mutants (Henseleit et al., 2005; Johansson et al., 2007).
Nkx6 Misexpression Prevents Acinar Cell
Differentiation
Next, we investigated whether continuous expression of Nkx6
factors throughout the entire pancreatic progenitor cell field is
sufficient to repress their differentiation into acinar cells. We
utilized the Pdx1 promoter to misexpress Nkx6.1 or Nkx6.2
(Figures 2A and 2H). As predicted, Pdx1-Nkx6.1 or Pdx1-DevelopmNkx6.2 embryos expressed Nkx6.1 or Nkx6.2, respectively,
throughout the entire pancreatic epithelium, including the
presumptive tip domain (Figures 2C, 2E, 2G, 2J, 2L, and 2N).
Organ size as well as Ngn3+ and endocrine cell numbers were
unaffected in Pdx1-Nkx6.1 and Pdx1-Nkx6.2 embryos
(Figure S2; data not shown), demonstrating that Nkx6 misex-
pression does not induce premature endocrine cell differentia-
tion. However, sustained expression of Nkx6.1 or Nkx6.2 signif-
icantly repressed Ptf1a expression (Figures 2B–2E and 2I–2L)
and consequently blocked acinar cell differentiation (Figures
2F, 2G, 2M, and 2N). Thus, the misexpression of either Nkx6.1
or Nkx6.2 in multipotent progenitors is sufficient to prevent the
initiation of an acinar program.
Nkx6.1 Specifies Endocrine Fate in Multipotent
Pancreatic Progenitors
To determine whether expression of Nkx6.1 predisposes multi-
potent pancreatic progenitors to adopt an endocrine fate, we
generatedCAG-Bgeo,-Nkx6.1,-eGFP transgenic mice (hereafter
abbreviated to Nkx6.1OE), in which concomitant expression of
Nkx6.1 and enhanced green fluorescent protein (eGFP) can be
stably and heritably induced by expression of Cre recombinase
(Figure 3B). The transgene design is analogous to that used in
CAG-Bgeo,-eGFP (Z/EG) mice, in which lacZ is ubiquitously
expressed in all cells unless Cre recombinase-mediated excision
removes the lacZ gene and allows for expression of eGFP
(Figure 3A). Z/EG mice therefore serve as a control for the
Nkx6.1OE model. To validate the Nkx6.1OE transgenic model,
we intercrossedNkx6.1OEwith Pdx1-CreERTMmice and induced
Cre-mediated recombination by administration of tamoxifen
(TM) to pregnant dams. As expected, the majority of unrecom-
bined cells expressed b-galactosidase (b-gal) but not GFP,
whereas recombined cells coexpressed Nkx6.1 and GFP but
were negative for b-gal (Figure S3A). No GFP expression was
observed in Nkx6.1OE mice without the Pdx1-CreERTM trans-
gene (Figure S3B), thus demonstrating no leakiness in our
system. These results were confirmed for mouse lines estab-
lished from two independent founders.
To analyze whether stable, heritable expression of Nkx6.1
biases the cell fate choice of multipotent progenitors, we in-
jected mice with TM at e8.5, which results in nuclear transloca-
tion of CreERTM and mosaic induction of Nkx6.1 and GFP in
Pdx1+ progenitors for a period of12–36 hr after TM administra-
tion (Zhou et al., 2007). To assess subsequent progenitor cell
fate, we quantified the percentages of recombined cells that
had initiated expression of specific lineage markers at different
time points following induction of Nkx6.1 expression. At e10.5,
when Nkx6.1 and Ptf1a are still coexpressed in most progenitors
(Figure 1A), Nkx6.1-misexpressing cells showed the same
propensity to activate the pre-endocrine markers Ngn3 and
Pax6, hormones, or Ptf1a as normal progenitors (Figures 3C–
3K). This suggests that progenitors are either not competent to
repress Ptf1a in response to Nkx6.1 prior to e10.5 or that the
time window between TM-mediated Nkx6.1 induction and
analysis is too short to observe a response. By e12.5, however,
we observed preferential activation of pre-endocrine markers
in cells that heritably expressed Nkx6.1 (Figures 3L–3N, 3R–3T,
and 3X). Crucially, we found that this increase in pre-endocrine
cells was not the result of increased cell proliferationental Cell 18, 1022–1029, June 15, 2010 ª2010 Elsevier Inc. 1023
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Figure 1. Endocrine-to-Acinar Fate Conversion in Nkx6-Deficient Embryos
(A–D) Immunofluorescence for Ptf1a and Nkx6.1 or Nkx6.2 in the embryonic mouse pancreas. At e12.5, Nkx6.1 and Nkx6.2 become excluded from the Ptf1a+ tip
domain.
(E and F) Quantification ofmRNA levels for acinarmarkers bymicroarray (E) and qRT-PCR (F) in e15.5 pancreas. Nkx6.1 deficiency results in increased expression
of acinar-specific genes.
(G–I, K–M, and P–R) Immunofluorescence staining reveals expansion of the Ptf1a+ domain into the trunk region inNkx6.1/ and Nkx6.1/;Nkx6.2/ pancreata
at e12.5. Concomitantly, Ngn3+ cells are reduced. At e14.5, Nkx6-deficient embryos show increased numbers of acinar cells.
(J, N, O, S, and T) Quantification of marker+ cells relative to total pancreatic area.
Scale bars represent 50 mm. Try, trypsin; Klk, kallikrein; Ela, elastase; Clps, colipase; Cel, carboxylester-lipase; Amy, amylase. Values are shown as mean ±
standard error of the mean.
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Figure 2. Nkx6 Proteins Suppress Acinar
Cell Differentiation
(A andH) Schematic of thePdx1-Nkx6.1 andPdx1-
Nkx6.2 transgenes.
(B–G and I–N) Immunofluorescence staining of
pancreata from Pdx1-Nkx6.1 embryos at e12.5
and e14.5 (B–G) and Pdx1-Nkx6.2 embryos at
e14.5 (I–N) shows that ectopic expression of
Nkx6.1 or Nkx6.2 blocks expression of Ptf1a and
amylase.
Scale bars represent 50 mm. Amy, amylase.
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Cross-Repression Determines Pancreatic Cell Fate(Figures 3Q, 3W, and 3X), but was accompanied by a concomi-
tant decrease of progenitors that had activated the preacinar
lineage markers Ptf1a and CPA (Figures 3O, 3P, 3U, 3V, and
3X). These results provide unequivocal evidence that Nkx6.1
controls a cell lineage choice between endocrine and acinar
fates in a critical time window preceding final lineage commit-
ment of the entire tip and trunk domains.
By e15.5, most Nkx6.1-misexpressing progenitors had
contributed to the endocrine cell compartment, whereas very
few progenitors had committed to an acinar fate (Figures 3Y,
3Z, 3D0, 3E0, and 3I0; Figures S3C–S3O). Nkx6.1 also increased
the propensity of progenitors to contribute to the Sox9+/
Hnf1b+ domain (Figures 3A0, 3B0, 3F0, 3G0, and 3I0), which is bipo-
tential and gives rise to both endocrine and ductal cells (Solar
et al., 2009). Because Nkx6.1-misexpressing cells that arose
from this domain preferentially activated endocrine markers
and not the ductal marker DBA (Figures 3C0, 3H0, and 3I0), we
conclude that expression of Nkx6.1 favors an endocrine over
a ductal cell fate choice. In sum, our findings suggest a model
whereby Nkx6.1 first establishes a bipotential ductal/endocrine
compartment by excluding Ptf1a and subsequently promotes
an endocrine fate choice in this secondary progenitor domain
(Figure 3J0).
Because Nkx6.1 functions as a transcriptional repressor (Muhr
et al., 2001), we tested whether Nkx6.1 is capable of directly
controlling acinar gene transcription. Adenoviral misexpression
of Nkx6.1 in the AR42J pancreatic acinar cell line resulted in
a significant suppression of Ptf1a, amylase 2, carboxypeptidase
A1, and elastase 1 mRNA and protein levels (Figures S4A and
S4B). Because Ptf1a is an upstream regulator of acinar geneDevelopmental Cell 18, 1022–102transcription (Krapp et al., 1996; Rose
et al., 2001), we next examined whether
Nkx6.1 controls acinar gene expression
by directly regulating Ptf1a transcription.
We identified 14 conserved Nkx6 binding
motifs (Jorgensen et al., 1999; Mirmira
et al., 2000) within 50 kb of the 50 end
flanking region from the Ptf1a transcrip-
tional start site, of which 8 were located
in a previously characterized 2.3 kb
Ptf1a enhancer (Figure S4C) (Masui
et al., 2008). This enhancer is sufficient
to initiate expression of a reporter trans-
gene in early pancreatic progenitors and
to superinduce Ptf1a expression in acinar
cells. Chromatin immunoprecipitation(ChIP) analysis in bTC3 cells revealed direct and specific associ-
ation of Nkx6.1 with the proximal part of the Ptf1a enhancer (E5),
whereas no association was observedwith the other Nkx6motifs
within or outside the enhancer region (Figure S4D). Transfection
of 266-6 acinar cells with an expression plasmid for Nkx6.1 and
a luciferase reporter construct controlled by the Ptf1a enhancer
sequence further revealed that Nkx6.1 significantly reduced
reporter gene activity (Figure S4E). This effect was blunted
when the Nkx6 binding site was mutated. Likewise, Nkx6.2
also repressed the Ptf1a enhancer, albeit less potently than
Nkx6.1 (Figure S4E). These findings illustrate that Nkx6 proteins
have the ability to directly repress Ptf1a gene transcription.
However, contrary to our observations in early progenitors,
Nkx6.1 did not completely repress Ptf1a when misexpressed in
acinar cells of embryos at e14.5 or of adult mice (data not shown;
Figures S3P and S3Q). This difference in responsiveness to Nkx6
repressors might be explained by the strong Ptf1a autoregula-
tory feedback loop that reinforces Ptf1a expression in mature
acinar cells (Masui et al., 2008). We also found that induction
of Nkx6.1 expression in Ptf1a+ cells at e14.5 or thereafter failed
to induce acinar-to-endocrine fate conversion (data not shown),
revealing that the ability of Nkx6 proteins to fully repress
Ptf1a and to confer endocrine identity to a cell is confined to
a critical early competence window, when progenitors are still
multipotent.
Ptf1a Represses Nkx6.1 and Adoption of Endocrine Fate
The antagonistic interplay between lineage-determining tran-
scription factors has previously been proposed as a molecular
mechanism for initiating and resolving mixed lineage states in9, June 15, 2010 ª2010 Elsevier Inc. 1025
P
d
x
1
-
C
r
e
E
R
T
M
;
N
k
x
6
.
1
O
E
CreER
TM
Pdx1
pCAGG
GFP
x
Tamoxifen
e8.5
lacZ
pCAGG
GFP
(Z/EG)
CreER
TM
Pdx1
x
lacZ
pCAGG
GFPNkx6.1
pCAGG
GFPNkx6.1
Tamoxifen
e8.5
(Nkx6.1
OE
)
Multipotent
progenitor
Endo/Duct
Ac
Endo
Duct
Nkx6.1
Multipotent
progenitor
Endo/Duct
Ac
Endo
Duct
Nkx6.1
PF
G
 
%
P
d
x
1
-
C
r
e
E
R
T
M
;
Z
/
E
G
e15.5
Horm/GFP Amy/GFP Sox9/GFP Hnf1β/GFP DBA/GFP
P
d
x
1
-
C
r
e
E
R
T
M
;
Z
/
E
G
P
d
x
1
-
C
r
e
E
R
T
M
;
N
k
x
6
.
1
O
E
Ptf1a/GFPNgn3/GFP Pax6/GFP Horm/GFP
e10.5
0
10
20
30
40
50
60
70
Ngn3+ Pax6+ Horm+ Ptf1a+
Pdx1CreERTM; 
Z/EG
Pdx1CreERTM; 
Nkx6.1OE
%
 G
FP
e10.5
e12.5
Ptf1a/GFPHorm/GFPPax6/GFPNgn3/GFP CPA/GFP Ki67/GFP
P
d
x
1
-
C
r
e
E
R
T
M
;
Z
/
E
G
P
d
x
1
-
C
r
e
E
R
T
M
;
N
k
x
6
.
1
O
E
0
10
20
30
40
50
60
%
 G
FP
Ngn3+ Pax6+ Horm+ Ptf1a+ CPA+ Ki67+
*
*
*
*
*
e12.5 Pdx1CreERTM; 
Z/EG
Pdx1CreERTM; 
Nkx6.1OE
0
10
20
30
40
Horm+ Amy+ Sox9+ Hnf1β+ DBA+
*
*
Pdx1CreERTM; 
Z/EG
Pdx1CreERTM; 
Nkx6.1OE
e15.5
A B
J'I'Z A' B' C'
E' F' G' H'
C D E F
G H I J
L M N O P Q
R S T U V W
X
K
Y
D'
Figure 3. Nkx6.1 Functions as an Endocrine Fate Determinant
A tamoxifen-inducible form of Cre recombinase (CreERTM) expressed under the control of the Pdx1 promoter removes a floxed Bgeo (lacZ) cassette to perma-
nently activate expression of green fluorescent protein (GFP) from the Z/EG transgene (A) or Nkx6.1 and GFP from the Nkx6.1OE transgene (B). Immunofluores-
cence staining of pancreas sections from e10.5 (C–J), e12.5 (L–W), and e15.5 (Y–H0) Pdx1-CreERTM;Z/EG and Pdx1-CreERTM;Nkx6.1OE embryos injected with
one dose of tamoxifen at e8.5. Quantification of GFP+/marker+ cells relative to the total number of GFP+ cells at e10.5 (K), e12.5 (X), or e15.5 (I0). At e10.5, similar
numbers of GFP+ cells have initiated expression of the endocrine markers Ngn3, Pax6, and hormones in Pdx1-CreERTM;Nkx6.1OE and Pdx1-CreERTM;Z/EG
control embryos (K). Similar analysis at e12.5 reveals a preference of GFP+ cells in Pdx1-CreERTM;Nkx6.1OE embryos to express Ngn3, Pax6, and hormones,
while showing a decreased propensity to express Ptf1a and CPA (X). Expression of the proliferation marker Ki67 does not show a difference between the two
groups (X). At e15.5, GFP+ cells in Pdx1-CreERTM;Z/EG embryos express endocrine hormones (Y) as well as the acinar marker amylase (Z) (arrowheads in inset,
Y and Z). By contrast, in Pdx1-CreERTM;Nkx6.1OE embryos, GFP+/amylase+ cells are rarely found (E0), whereas GFP+/hormone+ cells are abundantly detected
(arrowheads in inset, D0). GFP+ cells from Pdx1-CreERTM;Nkx6.1OE and Pdx1-CreERTM;Z/EG embryos have a similar potential to differentiate into DBA+ ductal
cells (arrowheads in inset show GFP+/DBA+ cells, C0 and H0).
(J0) Model of cell fate shifts induced by heritable Nkx6.1 misexpression in multipotent pancreatic progenitors.
Scale bars represent 50 mm. Triangles, loxP sites; filled ovals, IRES; Amy, amylase; Horm, hormones (insulin, glucagon, somatostatin, pancreatic polypeptide);
Endo, endocrine; Ac, acinar. Values are shown as mean ± standard error of the mean.
Developmental Cell
Cross-Repression Determines Pancreatic Cell Fateseveral tissues (Briscoe et al., 2000; Laslo et al., 2006; Olguin
et al., 2007). To elucidate whether pancreatic endocrine versus
acinar cell identity is established through a similar cross-antag-
onism, we tested whether uniform and sustained expression of
Ptf1a in all pancreatic progenitors is also sufficient to repress
Nkx6.1 and block endocrine cell differentiation. To direct Ptf1a
expression ectopically to the entire pancreatic epithelium, we
generated transgenic embryos that express Ptf1a under the
control of Pdx1 regulatory sequences (Figure 4A). Embryos
were harvested at e14.5 and analyzed for transgene expression
by immunofluorescence staining for the Ptf1a-FLAG fusion
protein. Of 18 embryos exhibiting genomic integration of the
transgene, 4 showed uniform expression of Ptf1a-FLAG
throughout most of the pancreatic epithelium, including the trunk1026 Developmental Cell 18, 1022–1029, June 15, 2010 ª2010 Elsevdomain from which Ptf1a is normally excluded (Figures 4B, 4E,
4F, and 4I). Strikingly, the majority of Ptf1a+ cells in Pdx1-Ptf1a
embryos were devoid of Nkx6.1 protein (Figures 4F and 4H),
showing that Ptf1a expression in progenitors is sufficient to
suppress Nkx6.1 (4/4 embryos). Likewise, ectopic Ptf1a also
repressed expression of the trunk marker Sox9 as well as
Ngn3 (Figures 4D and 4H) and thus completely abrogated endo-
crine cell differentiation (Figures 4E and 4I; 4/4 embryos). The
observation that not all Ptf1a+ cells in Pdx1-Ptf1a embryos acti-
vated expression of amylase (Figures 4F and 4G) suggests that
Ptf1a misexpression did not induce premature acinar differenti-
ation.We conclude that the sustained expression of Ptf1a inmul-
tipotent progenitors is sufficient to block the expression of trunk
markers and prevent endocrine differentiation.ier Inc.
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Figure 4. Ptf1a Is a Repressor of Endocrine Fate
(A) Schematic of the Pdx1-Ptf1a transgene.
(B–I) Immunofluorescence staining of adjacent pancreas sections from e14.5 embryos shows ectopic expression of Ptf1a (F) and FLAG (I) in the trunk region of
Pdx1-Ptf1a embryos. Ptf1a misexpression does not uniformly induce amylase expression (yellow arrowheads, F and G). Ectopic Ptf1a represses Nkx6.1, Sox9,
and Ngn3 (H), and prevents endocrine cell differentiation (I). White arrowheads in (F) and (H) point to a region that does not misexpress Ptf1a and therefore
expresses Sox9 and Nkx6.1. Insets in (D) and (H) show higher magnifications.
(J and K) Immunofluorescence staining of adjacent pancreatic sections from Pdx1-Cre(mosaic);R26NotchIC embryos at e15.5 shows expression of Nkx6.1 in all
cells that have recombined the R26NotchIC allele and therefore activated NotchIC/GFP expression. Ptf1a is excluded from the GFP+ domain, but is expressed in
areas that have not recombined the R26NotchIC allele (arrowheads, J and K).
(L) Summary of the observed cell fate changes in Nkx6 loss- and gain-of-function models.
(M) Our data support a model whereby a regulatory circuit composed of the counter-antagonistic repressive activities of Nkx6 and Ptf1a restricts multipotent
pancreatic progenitors to ductal/endocrine and acinar fates, respectively. Positive autoregulatory feedback of Nkx6 and Ptf1a creates bistability of the fate
choice. High Notch activity appears to favor the Nkx6.1+ state. Note, for simplicity, the redundant factors Nkx6.1 and Nkx6.2 are referred to as Nkx6.
Scale bars represent 50 mm. Amy, amylase; Horm, hormones (insulin, glucagon, somatostatin, pancreatic polypeptide); Endo, endocrine; Ac, acinar.
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activity results in endocrine-to-acinar cell fate conversion of
Ngn3+ progenitors, suggesting that fate commitment remains
plastic even in Ngn3+ cells (Cras-Meneur et al., 2009). To deter-
mine whether the Nkx6/Ptf1a switch might operate downstream
of Notch, we employed a mosaic Pdx1-Cre transgene to herit-
ably activate Notch1 in multipotent progenitors, using the
R26NotchIC allele (Murtaugh et al., 2003). All cells that recombined
the R26NotchIC allele and therefore expressed NotchIC and GFP
were Nkx6.1+ but Ptf1a, whereas cells that failed to undergo
Cre-mediated recombination were Ptf1a+ but Nkx6.1 (Figures
4J and 4K). These findings indicate that Notch signaling favors
the expression of Nkx6.1 and the exclusion of Ptf1a in multipo-
tent progenitors. This might be achieved either through the direct
activation of Nkx6.1 by Notch or, alternatively, by Notch indi-
rectly allowing for Nkx6.1 expression by repressing Ptf1a. TakenDevelopmtogether, our data demonstrate that a Notch-controlled cross-
antagonistic switch between Nkx6 and Ptf1a restricts multipo-
tent progenitors in the developing pancreas to either a ductal/
endocrine or acinar cell fate (Figures 4L and 4M).
DISCUSSION
Although reciprocal repression mechanisms are known to regu-
late cell lineage commitment in many tissues (Briscoe et al.,
2000; Laslo et al., 2006; Olguin et al., 2007), our study demon-
strates that this mechanism also operates during organogenesis
of the pancreas. Paralleling their role in pancreatic endocrine cell
specification described herein, the redundant activities of
Nkx6.1 and Nkx6.2 also specify neuronal cell fate through the
repression of alternative neuronal fate choices (Sander et al.,
2000a; Vallstedt et al., 2001). An analogous role has also beenental Cell 18, 1022–1029, June 15, 2010 ª2010 Elsevier Inc. 1027
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(Fujitani et al., 2006). Recent analysis of zebrafish with a hypo-
morphic allele for Ptf1a has further shown that loss of Ptf1a
activity induces an acinar-to-endocrine fate conversion of
Ptf1a+ pancreatic progenitors (Dong et al., 2008), suggesting
that Ptf1a commits progenitors to an acinar cell fate. Together
with the findings described in this study, these observations
point to a developmentally conserved role for Nkx6 proteins
and Ptf1a as a counter-regulatory switch for specifying distinct
lineages in multipotent progenitors. Notably, Nkx6.1 and Ptf1a
both maintain their own expression through a direct positive-
feedbackmechanism (Iype et al., 2004;Masui et al., 2008), which
provides stability to the genetic switch and thereby reinforces
a cell-specific program of gene expression.
Our findings indicate that the Nkx6-to-Ptf1a arm of the repres-
sive loop could be mediated by direct transcriptional repression
of Ptf1a by Nkx6 proteins. The absence of a suitable in vitro
system for primary pancreatic progenitor cells precluded exper-
iments to test whether the direct repression of the Ptf1a
enhancer by Nkx6.1 or Nkx6.2 that we observed in cell lines
also occurs in embryonic progenitors. However, the observation
that the Ptf1a enhancer to which Nkx6.1 binds and which it
represses in acinar cell lines is active in both mature acinar cells
and multipotent progenitors of the embryonic pancreas (Masui
et al., 2008) favors the notion that its repression by Nkx6 factors
could also be relevant during acinar cell specification in the
embryo. Because Ptf1a largely functions as a transcriptional
activator (Masui et al., 2008; Rose et al., 2001), it appears,
however, less likely that Ptf1a represses Nkx6.1 directly.
One critical aspect of our findings is that the Nkx6/Ptf1a switch
only operates during a competence window prior to e14, when
Ptf1a+ progenitors are still multipotent. The closure of this time
window coincides with the irreversible lineage commitment of
tip cells to an acinar fate and trunk cells to a ductal or endocrine
fate (Solar et al., 2009; Zhou et al., 2007). Our observation that
Nkx6.1 induces a fate bias as early as e12.5 reveals that lineage
commitment is initiated early and suggests that a substantial
proportion of progenitors may have committed to an acinar or
ductal/endocrine fate well before the trunk and tip domains
become visually distinguishable. This early specification event
mediated by cross-antagonism between Nkx6 factors and
Ptf1a may therefore represent an intrinsic mechanism by which
the relative numbers of newly differentiated endocrine versus
acinar cells are predetermined during pancreas development.
Neither expression of Nkx6 factors nor Ptf1a accelerated cell
differentiation in our gain-of-function models. Therefore, Nkx6
proteins and Ptf1a appear to primarily function as cell fate deter-
minants, whereas other factors, such as Ngn3 in the case of the
endocrine lineage (Apelqvist et al., 1999; Schwitzgebel et al.,
2000), are required to initiate differentiation of prespecified
progenitors into the various cell types of the mature pancreas.
This notion is consistent with our observation that Nkx6 factors
specify endocrine cell fate upstreamofNgn3. In caseof the acinar
lineage, Ptf1a itself appears to be involved in the induction of
acinar cell differentiation,but its activity is refinedandconstrained
by the availability of specific cofactors (Masui et al., 2007).
In summary, our study demonstrates the importance of
a reciprocal repression mechanism in dictating cell fate choices
in multipotent progenitors during pancreas development. It1028 Developmental Cell 18, 1022–1029, June 15, 2010 ª2010 Elsevprovides a functional framework in which to investigate the
molecular mechanisms associated with the transition of progen-
itors from amultipotent to a lineage-committed state. Insight into
themolecular underpinnings of this processmay help in devising
strategies to induce endocrine commitment for clinical applica-
tions in diabetes.
EXPERIMENTAL PROCEDURES
Transgene Construction and Mice
Nkx6.1/, Pdx1-Nkx6.1, Pdx1-Nkx6.2,CAG-Bgeo,-eGFP, and Pdx1-CreERTM
mice have been previously described (Gu et al., 2002; Nelson et al., 2007;
Novak et al., 2000; Sander et al., 2000b). The generation of CAG-Bgeo,-
Nkx6.1,-eGFP and Pdx1-Ptf1a mice is described in Supplemental Experi-
mental Procedures. All animal experiments described herein were approved
by University of California, Irvine and San Diego Institutional Animal Care
and Use Committees.
Tamoxifen (Sigma) was dissolved in corn oil (Sigma) at 20 mg/ml, and
a single dose of 2 mg/40 g body weight was administered by intraperitoneal
injection at e8.5. Midday on the day of vaginal plug appearance was consid-
ered e0.5.
Immunohistochemistry, X-Gal Staining, Morphometry, and Cell
Quantification
Tissue preparation, immunohistochemistry, X-gal staining, TUNEL staining,
and morphometry were performed as previously described (Seymour et al.,
2008). A detailed description of the morphometric methods is also included
in Supplemental Experimental Procedures. All values are shown as mean ±
standard error of the mean (SEM); p values were calculated using unpaired
Student’s t test; p < 0.05 was considered significant.
mRNA Quantification
Microarray analyses were performed in triplicate for each genotype. Total RNA
was isolated from three Nkx6.1/ embryos or wild type littermates at e15.5
and pooled to hybridize to an Affymetrix gene chip (MG_U74A). We used prin-
cipal components analysis to identify patterns of gene expression.
For qRT-PCR, RNA was isolated with the RNeasy Mini Kit (QIAGEN) and
treated with DNase. Synthesis of cDNA was performed with the Superscript
III cDNA Kit (Invitrogen). Quantitative PCR reactions were performed in tripli-
cate using SYBR green (Applied Biosystems).
A list of primer sequences for qRT-PCR analysis and of antibodies and their
dilutions can be found in Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and three tables and can be found with this article online at
doi:10.1016/j.devcel.2010.05.015.
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